Expected contributions should be from a broad and interdisciplinary perspective: marketing, communication, management, information science, psychology, sociology, economy, public health, etc. Expected papers should be related to one or more of the following thematic axis (the various thematic discussed herewith are indicative and non–exhaustive):
Axis 1: to question the needs for a functional and strategic marketing approach for the health institutions – hospitals and other healthcare institutions – (e.g. ownership of the marketing process, market orientation, internal–external interactive marketing, competition, cooperation and “coopetition”, T2A and marketing strategy, etc.).
Axis 2: Social marketing and public health, deviant behaviour prevention within the health context (e.g.: new modes, modalities and codes in the communication process, advocacy, therapeutic education, from communication on disease towards communication on health, etc).
Axis 3: Transversal issues in the health sector (e.g. pricing in health services, database and health industry, choices and arbitration in health, “disease management”, therapeutic education, etc.).
Axis 4: Pharmaceutical industry, health products and biomedical material marketing, health equipment′s industry and services, the industry of health–nutrition–beauty, etc. Evolution, revolution and perspectives (e.g. from the passive patient to the prescriptive patient, alternative markets for drugs, major conceptual shift presently occurring– from chemistry to genetic, from mass treatment to individualized curing, from acute to chronic, from curing to preventing, from push to pull, from patents to generics, from prescription to auto medication, global versus local, communication toward D2C, new stakeholders, etc.).
|